心室导联植入后三尖瓣关闭不全
Tricuspid valve incompetence following implantation of ventricular leads.
作者信息
Baquero Giselle A, Luck Jerry, Naccarelli Gerald V, Gonzalez Mario D, Banchs Javier E
机构信息
Division of Cardiology, Department of Medicine, Penn State College of Medicine, Penn State Hershey Heart and Vascular Institute, Penn State University, 500 University Drive. Mail Code H047, PO BOX 850, Hershey, PA, 17033, USA,
出版信息
Curr Heart Fail Rep. 2015 Apr;12(2):150-7. doi: 10.1007/s11897-014-0249-x.
Most cardiovascular implantable electronic devices (CIEDs) require a ventricular lead to be placed across the tricuspid valve. Tricuspid regurgitation (TR) is an understudied clinical complication of right ventricular lead implantation and its clinical significance is unknown. We review the incidence, predictors, and current management of TR as a complication of ventricular lead implantation. Emerging technologies, including leadless pacing devices and subcutaneous systems, offer the benefit of little or none tricuspid valve disruption.
大多数心血管植入式电子设备（CIED）需要将心室导线穿过三尖瓣放置。三尖瓣反流（TR）是右心室导线植入未得到充分研究的临床并发症，其临床意义尚不清楚。我们综述了作为心室导线植入并发症的TR的发生率、预测因素及当前治疗方法。包括无导线起搏设备和皮下系统在内的新兴技术具有几乎不破坏或不破坏三尖瓣的优点。
Zotero 插件